+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Allergy Vaccine Market - Global Forecast 2025-2030- Product Image
Allergy Vaccine Market - Global Forecast 2025-2030- Product Image
Sale

Allergy Vaccine Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 195 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 4905049
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The allergy vaccine market is entering a dynamic phase, shaped by technological innovation, evolving regulation, and changing patient and market needs. Stakeholders now face complex considerations that span scientific advances, operational agility, and global supply chain risk. This report provides a strategic overview for senior leaders seeking to understand and capitalize on emerging trends within allergy immunotherapy.

Market Snapshot: Allergy Vaccine Market Size and Growth

The Allergy Vaccine Market grew from USD 1.43 billion in 2024 to USD 1.60 billion in 2025. It is expected to continue growing at a CAGR of 11.55%, reaching USD 2.75 billion by 2030. Robust expansion reflects advancements in immunotherapy science, broadening patient bases, and heightened demand for both traditional and novel allergy management solutions.

Scope & Segmentation

This research delivers a comprehensive analysis across multiple market dimensions and patient access pathways. The scope encompasses:

  • Route of Administration: Subcutaneous immunotherapy (accelerated, standard), sublingual immunotherapy (drops, tablets).
  • Allergens Targeted: Perennial allergens (animal dander, dust mite), seasonal allergens (molds, pollen).
  • Vaccine Type: Monovalent, polyvalent.
  • Distribution Channel: Hospital pharmacies, online pharmacies, retail pharmacies.
  • Technology: Recombinant, traditional extract.
  • Patient Age Group: Adult, geriatric, pediatric.
  • End User: Clinics, home healthcare, hospitals.
  • Regional Coverage: Americas (United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (including major countries), Asia-Pacific (China, India, Japan, Australia, and others).
  • Leading Companies: ALK-Abelló A/S, Stallergenes Greer LLC, Allergopharma GmbH & Co. KG, Merck & Co., Inc., DBV Technologies S.A., Allergy Therapeutics plc, Laboratorios LETI S.L., HAL Allergy B.V., Bencard Allergie GmbH, Torii Pharmaceutical Co., Ltd.

Key Takeaways for Senior Decision-Makers

  • The allergy vaccine market is evolving beyond conventional extract-based products, with recombinant and epitope-mapping approaches gaining traction. This enhances antigen specificity and supports the shift toward precision immunotherapy.
  • Regulatory frameworks are adapting to new technologies, fostering accelerated approval pathways and integration of real-world evidence in decision-making. Companies positioned for early engagement benefit from reduced approval time and greater input into clinical endpoints.
  • Emerging delivery modalities, including needle-free and sublingual options, are broadening patient acceptance by reducing barriers and improving adherence. Digital health tools are increasingly used to monitor treatment and support remote dosing.
  • Segmentation analysis highlights varying needs across age groups and clinical settings, prompting tailored strategies for pediatric, adult, and geriatric populations. Distinct distribution strategies are vital for home care, clinics, and hospitals alike.
  • Regional considerations significantly affect go-to-market strategies, supply chain design, and regulatory compliance, especially across the Americas, EMEA, and Asia Pacific. Aligning with localized market drivers is critical for success.
  • Partnerships between large biopharmaceutical leaders and agile, innovation-focused biotech firms are accelerating candidate development and optimizing market readiness.

Tariff Impact on the Allergy Vaccine Market

Newly implemented trade duties on raw materials, including adjuvant precursors and enzyme substrates, are influencing manufacturing costs and sourcing models. Industry response includes supply chain realignment, negotiations with domestic vendors, and strategic stockpiling to offset volatility. Regulatory support for clinical trial material importation and cross-industry collaboration helps mitigate financial pressures, fostering supply chain resilience and cost optimization.

Methodology & Data Sources

This report synthesizes structured interviews with immunology specialists, regulatory advisors, and supply chain experts, combined with analysis of peer-reviewed literature, patent data, and regulatory documents. Scenario modeling and sensitivity analysis ensure reliable, actionable insight for strategy formulation.

Why This Report Matters

  • Enables senior executives to benchmark product portfolios and market positions in a rapidly changing allergy vaccine landscape.
  • Clarifies the health policy and supply chain factors shaping future investment, regulatory engagement, and international expansion decisions.
  • Equips leaders with actionable segmentation and regional insights to optimize production, market entry, and risk mitigation strategies grounded in real-world clinical need.

Conclusion

The allergy vaccine market is progressing rapidly, shaped by innovation, regulation, and shifting global priorities. Executives equipped with this report can confidently chart the next steps in immunotherapy development and delivery.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Adoption of nanoparticle delivery systems to enhance immunogenicity in allergy vaccines
5.2. Integration of machine learning algorithms to tailor allergy vaccine formulations to individual patient profiles
5.3. Emergence of hypoallergenic recombinant allergens improving safety profiles in immunotherapy treatments
5.4. Strategic partnerships between biotech firms and academic institutions driving innovative allergy vaccine research
5.5. Regulatory approvals of sublingual immunotherapy products expanding market access in emerging economies
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Allergy Vaccine Market, by Route Of Administration
8.1. Introduction
8.2. Subcutaneous Immunotherapy
8.2.1. Accelerated Doses
8.2.2. Standard Doses
8.3. Sublingual Immunotherapy
8.3.1. Drops
8.3.2. Tablets
9. Allergy Vaccine Market, by Allergens Targeted
9.1. Introduction
9.2. Perennial Allergens
9.2.1. Animal Dander
9.2.2. Dust Mite
9.3. Seasonal Allergens
9.3.1. Molds
9.3.2. Pollen
10. Allergy Vaccine Market, by Vaccine Type
10.1. Introduction
10.2. Monovalent
10.3. Polyvalent
11. Allergy Vaccine Market, by Distribution Channel
11.1. Introduction
11.2. Hospital Pharmacies
11.3. Online Pharmacies
11.4. Retail Pharmacies
12. Allergy Vaccine Market, by Technology
12.1. Introduction
12.2. Recombinant
12.3. Traditional Extract
13. Allergy Vaccine Market, by Patient Age Group
13.1. Introduction
13.2. Adult
13.3. Geriatric
13.4. Pediatric
14. Allergy Vaccine Market, by End User
14.1. Introduction
14.2. Clinics
14.3. Home Healthcare
14.4. Hospitals
15. Americas Allergy Vaccine Market
15.1. Introduction
15.2. United States
15.3. Canada
15.4. Mexico
15.5. Brazil
15.6. Argentina
16. Europe, Middle East & Africa Allergy Vaccine Market
16.1. Introduction
16.2. United Kingdom
16.3. Germany
16.4. France
16.5. Russia
16.6. Italy
16.7. Spain
16.8. United Arab Emirates
16.9. Saudi Arabia
16.10. South Africa
16.11. Denmark
16.12. Netherlands
16.13. Qatar
16.14. Finland
16.15. Sweden
16.16. Nigeria
16.17. Egypt
16.18. Turkey
16.19. Israel
16.20. Norway
16.21. Poland
16.22. Switzerland
17. Asia-Pacific Allergy Vaccine Market
17.1. Introduction
17.2. China
17.3. India
17.4. Japan
17.5. Australia
17.6. South Korea
17.7. Indonesia
17.8. Thailand
17.9. Philippines
17.10. Malaysia
17.11. Singapore
17.12. Vietnam
17.13. Taiwan
18. Competitive Landscape
18.1. Market Share Analysis, 2024
18.2. FPNV Positioning Matrix, 2024
18.3. Competitive Analysis
18.3.1. ALK-Abelló A/S
18.3.2. Stallergenes Greer LLC
18.3.3. Allergopharma GmbH & Co. KG
18.3.4. Merck & Co., Inc.
18.3.5. DBV Technologies S.A.
18.3.6. Allergy Therapeutics plc
18.3.7. Laboratorios LETI, S.L.
18.3.8. HAL Allergy B.V.
18.3.9. Bencard Allergie GmbH
18.3.10. Torii Pharmaceutical Co., Ltd.
19. ResearchAI
20. ResearchStatistics
21. ResearchContacts
22. ResearchArticles
23. Appendix
List of Figures
FIGURE 1. ALLERGY VACCINE MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL ALLERGY VACCINE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL ALLERGY VACCINE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL ALLERGY VACCINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL ALLERGY VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 6. GLOBAL ALLERGY VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL ALLERGY VACCINE MARKET SIZE, BY ALLERGENS TARGETED, 2024 VS 2030 (%)
FIGURE 8. GLOBAL ALLERGY VACCINE MARKET SIZE, BY ALLERGENS TARGETED, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL ALLERGY VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 12. GLOBAL ALLERGY VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL ALLERGY VACCINE MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 14. GLOBAL ALLERGY VACCINE MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL ALLERGY VACCINE MARKET SIZE, BY PATIENT AGE GROUP, 2024 VS 2030 (%)
FIGURE 16. GLOBAL ALLERGY VACCINE MARKET SIZE, BY PATIENT AGE GROUP, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL ALLERGY VACCINE MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 18. GLOBAL ALLERGY VACCINE MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. AMERICAS ALLERGY VACCINE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. AMERICAS ALLERGY VACCINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. UNITED STATES ALLERGY VACCINE MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 22. UNITED STATES ALLERGY VACCINE MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA ALLERGY VACCINE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA ALLERGY VACCINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ASIA-PACIFIC ALLERGY VACCINE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. ASIA-PACIFIC ALLERGY VACCINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. ALLERGY VACCINE MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 28. ALLERGY VACCINE MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 29. ALLERGY VACCINE MARKET: RESEARCHAI
FIGURE 30. ALLERGY VACCINE MARKET: RESEARCHSTATISTICS
FIGURE 31. ALLERGY VACCINE MARKET: RESEARCHCONTACTS
FIGURE 32. ALLERGY VACCINE MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. ALLERGY VACCINE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL ALLERGY VACCINE MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL ALLERGY VACCINE MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL ALLERGY VACCINE MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL ALLERGY VACCINE MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL ALLERGY VACCINE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL ALLERGY VACCINE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL ALLERGY VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL ALLERGY VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL ALLERGY VACCINE MARKET SIZE, BY SUBCUTANEOUS IMMUNOTHERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL ALLERGY VACCINE MARKET SIZE, BY SUBCUTANEOUS IMMUNOTHERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL ALLERGY VACCINE MARKET SIZE, BY ACCELERATED DOSES, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL ALLERGY VACCINE MARKET SIZE, BY ACCELERATED DOSES, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL ALLERGY VACCINE MARKET SIZE, BY STANDARD DOSES, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL ALLERGY VACCINE MARKET SIZE, BY STANDARD DOSES, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL ALLERGY VACCINE MARKET SIZE, BY SUBCUTANEOUS IMMUNOTHERAPY, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL ALLERGY VACCINE MARKET SIZE, BY SUBCUTANEOUS IMMUNOTHERAPY, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL ALLERGY VACCINE MARKET SIZE, BY SUBLINGUAL IMMUNOTHERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL ALLERGY VACCINE MARKET SIZE, BY SUBLINGUAL IMMUNOTHERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL ALLERGY VACCINE MARKET SIZE, BY DROPS, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL ALLERGY VACCINE MARKET SIZE, BY DROPS, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL ALLERGY VACCINE MARKET SIZE, BY TABLETS, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL ALLERGY VACCINE MARKET SIZE, BY TABLETS, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL ALLERGY VACCINE MARKET SIZE, BY SUBLINGUAL IMMUNOTHERAPY, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL ALLERGY VACCINE MARKET SIZE, BY SUBLINGUAL IMMUNOTHERAPY, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL ALLERGY VACCINE MARKET SIZE, BY ALLERGENS TARGETED, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL ALLERGY VACCINE MARKET SIZE, BY ALLERGENS TARGETED, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL ALLERGY VACCINE MARKET SIZE, BY PERENNIAL ALLERGENS, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL ALLERGY VACCINE MARKET SIZE, BY PERENNIAL ALLERGENS, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL ALLERGY VACCINE MARKET SIZE, BY ANIMAL DANDER, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL ALLERGY VACCINE MARKET SIZE, BY ANIMAL DANDER, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL ALLERGY VACCINE MARKET SIZE, BY DUST MITE, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL ALLERGY VACCINE MARKET SIZE, BY DUST MITE, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL ALLERGY VACCINE MARKET SIZE, BY PERENNIAL ALLERGENS, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL ALLERGY VACCINE MARKET SIZE, BY PERENNIAL ALLERGENS, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL ALLERGY VACCINE MARKET SIZE, BY SEASONAL ALLERGENS, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL ALLERGY VACCINE MARKET SIZE, BY SEASONAL ALLERGENS, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL ALLERGY VACCINE MARKET SIZE, BY MOLDS, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL ALLERGY VACCINE MARKET SIZE, BY MOLDS, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL ALLERGY VACCINE MARKET SIZE, BY POLLEN, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL ALLERGY VACCINE MARKET SIZE, BY POLLEN, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL ALLERGY VACCINE MARKET SIZE, BY SEASONAL ALLERGENS, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL ALLERGY VACCINE MARKET SIZE, BY SEASONAL ALLERGENS, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL ALLERGY VACCINE MARKET SIZE, BY MONOVALENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL ALLERGY VACCINE MARKET SIZE, BY MONOVALENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL ALLERGY VACCINE MARKET SIZE, BY POLYVALENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL ALLERGY VACCINE MARKET SIZE, BY POLYVALENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL ALLERGY VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL ALLERGY VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL ALLERGY VACCINE MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL ALLERGY VACCINE MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL ALLERGY VACCINE MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL ALLERGY VACCINE MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL ALLERGY VACCINE MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL ALLERGY VACCINE MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL ALLERGY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL ALLERGY VACCINE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL ALLERGY VACCINE MARKET SIZE, BY RECOMBINANT, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL ALLERGY VACCINE MARKET SIZE, BY RECOMBINANT, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL ALLERGY VACCINE MARKET SIZE, BY TRADITIONAL EXTRACT, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL ALLERGY VACCINE MARKET SIZE, BY TRADITIONAL EXTRACT, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL ALLERGY VACCINE MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL ALLERGY VACCINE MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL ALLERGY VACCINE MARKET SIZE, BY ADULT, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL ALLERGY VACCINE MARKET SIZE, BY ADULT, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL ALLERGY VACCINE MARKET SIZE, BY GERIATRIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL ALLERGY VACCINE MARKET SIZE, BY GERIATRIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL ALLERGY VACCINE MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL ALLERGY VACCINE MARKET SIZE, BY PEDIATRIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL ALLERGY VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL ALLERGY VACCINE MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL ALLERGY VACCINE MARKET SIZE, BY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL ALLERGY VACCINE MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL ALLERGY VACCINE MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL ALLERGY VACCINE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL ALLERGY VACCINE MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. AMERICAS ALLERGY VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 82. AMERICAS ALLERGY VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 83. AMERICAS ALLERGY VACCINE MARKET SIZE, BY SUBCUTANEOUS IMMUNOTHERAPY, 2018-2024 (USD MILLION)
TABLE 84. AMERICAS ALLERGY VACCINE MARKET SIZE, BY SUBCUTANEOUS IMMUNOTHERAPY, 2025-2030 (USD MILLION)
TABLE 85. AMERICAS ALLERGY VACCINE MARKET SIZE, BY SUBLINGUAL IMMUNOTHERAPY, 2018-2024 (USD MILLION)
TABLE 86. AMERICAS ALLERGY VACCINE MARKET SIZE, BY SUBLINGUAL IMMUNOTHERAPY, 2025-2030 (USD MILLION)
TABLE 87. AMERICAS ALLERGY VACCINE MARKET SIZE, BY ALLERGENS TARGETED, 2018-2024 (USD MILLION)
TABLE 88. AMERICAS ALLERGY VACCINE MARKET SIZE, BY ALLERGENS TARGETED, 2025-2030 (USD MILLION)
TABLE 89. AMERICAS ALLERGY VACCINE MARKET SIZE, BY PERENNIAL ALLERGENS, 2018-2024 (USD MILLION)
TABLE 90. AMERICAS ALLERGY VACCINE MARKET SIZE, BY PERENNIAL ALLERGENS, 2025-2030 (USD MILLION)
TABLE 91. AMERICAS ALLERGY VACCINE MARKET SIZE, BY SEASONAL ALLERGENS, 2018-2024 (USD MILLION)
TABLE 92. AMERICAS ALLERGY VACCINE MARKET SIZE, BY SEASONAL ALLERGENS, 2025-2030 (USD MILLION)
TABLE 93. AMERICAS ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 94. AMERICAS ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 95. AMERICAS ALLERGY VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 96. AMERICAS ALLERGY VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 97. AMERICAS ALLERGY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 98. AMERICAS ALLERGY VACCINE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 99. AMERICAS ALLERGY VACCINE MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 100. AMERICAS ALLERGY VACCINE MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 101. AMERICAS ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 102. AMERICAS ALLERGY VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 103. AMERICAS ALLERGY VACCINE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 104. AMERICAS ALLERGY VACCINE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 105. UNITED STATES ALLERGY VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 106. UNITED STATES ALLERGY VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 107. UNITED STATES ALLERGY VACCINE MARKET SIZE, BY SUBCUTANEOUS IMMUNOTHERAPY, 2018-2024 (USD MILLION)
TABLE 108. UNITED STATES ALLERGY VACCINE MARKET SIZE, BY SUBCUTANEOUS IMMUNOTHERAPY, 2025-2030 (USD MILLION)
TABLE 109. UNITED STATES ALLERGY VACCINE MARKET SIZE, BY SUBLINGUAL IMMUNOTHERAPY, 2018-2024 (USD MILLION)
TABLE 110. UNITED STATES ALLERGY VACCINE MARKET SIZE, BY SUBLINGUAL IMMUNOTHERAPY, 2025-2030 (USD MILLION)
TABLE 111. UNITED STATES ALLERGY VACCINE MARKET SIZE, BY ALLERGENS TARGETED, 2018-2024 (USD MILLION)
TABLE 112. UNITED STATES ALLERGY VACCINE MARKET SIZE, BY ALLERGENS TARGETED, 2025-2030 (USD MILLION)
TABLE 113. UNITED STATES ALLERGY VACCINE MARKET SIZE, BY PERENNIAL ALLERGENS, 2018-2024 (USD MILLION)
TABLE 114. UNITED STATES ALLERGY VACCINE MARKET SIZE, BY PERENNIAL ALLERGENS, 2025-2030 (USD MILLION)
TABLE 115. UNITED STATES ALLERGY VACCINE MARKET SIZE, BY SEASONAL ALLERGENS, 2018-2024 (USD MILLION)
TABLE 116. UNITED STATES ALLERGY VACCINE MARKET SIZE, BY SEASONAL ALLERGENS, 2025-2030 (USD MILLION)
TABLE 117. UNITED STATES ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 118. UNITED STATES ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 119. UNITED STATES ALLERGY VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 120. UNITED STATES ALLERGY VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 121. UNITED STATES ALLERGY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 122. UNITED STATES ALLERGY VACCINE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 123. UNITED STATES ALLERGY VACCINE MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 124. UNITED STATES ALLERGY VACCINE MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 125. UNITED STATES ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 126. UNITED STATES ALLERGY VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 127. UNITED STATES ALLERGY VACCINE MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 128. UNITED STATES ALLERGY VACCINE MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 129. CANADA ALLERGY VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 130. CANADA ALLERGY VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 131. CANADA ALLERGY VACCINE MARKET SIZE, BY SUBCUTANEOUS IMMUNOTHERAPY, 2018-2024 (USD MILLION)
TABLE 132. CANADA ALLERGY VACCINE MARKET SIZE, BY SUBCUTANEOUS IMMUNOTHERAPY, 2025-2030 (USD MILLION)
TABLE 133. CANADA ALLERGY VACCINE MARKET SIZE, BY SUBLINGUAL IMMUNOTHERAPY, 2018-2024 (USD MILLION)
TABLE 134. CANADA ALLERGY VACCINE MARKET SIZE, BY SUBLINGUAL IMMUNOTHERAPY, 2025-2030 (USD MILLION)
TABLE 135. CANADA ALLERGY VACCINE MARKET SIZE, BY ALLERGENS TARGETED, 2018-2024 (USD MILLION)
TABLE 136. CANADA ALLERGY VACCINE MARKET SIZE, BY ALLERGENS TARGETED, 2025-2030 (USD MILLION)
TABLE 137. CANADA ALLERGY VACCINE MARKET SIZE, BY PERENNIAL ALLERGENS, 2018-2024 (USD MILLION)
TABLE 138. CANADA ALLERGY VACCINE MARKET SIZE, BY PERENNIAL ALLERGENS, 2025-2030 (USD MILLION)
TABLE 139. CANADA ALLERGY VACCINE MARKET SIZE, BY SEASONAL ALLERGENS, 2018-2024 (USD MILLION)
TABLE 140. CANADA ALLERGY VACCINE MARKET SIZE, BY SEASONAL ALLERGENS, 2025-2030 (USD MILLION)
TABLE 141. CANADA ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 142. CANADA ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 143. CANADA ALLERGY VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 144. CANADA ALLERGY VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 145. CANADA ALLERGY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 146. CANADA ALLERGY VACCINE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 147. CANADA ALLERGY VACCINE MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 148. CANADA ALLERGY VACCINE MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 149. CANADA ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 150. CANADA ALLERGY VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 151. MEXICO ALLERGY VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 152. MEXICO ALLERGY VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 153. MEXICO ALLERGY VACCINE MARKET SIZE, BY SUBCUTANEOUS IMMUNOTHERAPY, 2018-2024 (USD MILLION)
TABLE 154. MEXICO ALLERGY VACCINE MARKET SIZE, BY SUBCUTANEOUS IMMUNOTHERAPY, 2025-2030 (USD MILLION)
TABLE 155. MEXICO ALLERGY VACCINE MARKET SIZE, BY SUBLINGUAL IMMUNOTHERAPY, 2018-2024 (USD MILLION)
TABLE 156. MEXICO ALLERGY VACCINE MARKET SIZE, BY SUBLINGUAL IMMUNOTHERAPY, 2025-2030 (USD MILLION)
TABLE 157. MEXICO ALLERGY VACCINE MARKET SIZE, BY ALLERGENS TARGETED, 2018-2024 (USD MILLION)
TABLE 158. MEXICO ALLERGY VACCINE MARKET SIZE, BY ALLERGENS TARGETED, 2025-2030 (USD MILLION)
TABLE 159. MEXICO ALLERGY VACCINE MARKET SIZE, BY PERENNIAL ALLERGENS, 2018-2024 (USD MILLION)
TABLE 160. MEXICO ALLERGY VACCINE MARKET SIZE, BY PERENNIAL ALLERGENS, 2025-2030 (USD MILLION)
TABLE 161. MEXICO ALLERGY VACCINE MARKET SIZE, BY SEASONAL ALLERGENS, 2018-2024 (USD MILLION)
TABLE 162. MEXICO ALLERGY VACCINE MARKET SIZE, BY SEASONAL ALLERGENS, 2025-2030 (USD MILLION)
TABLE 163. MEXICO ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 164. MEXICO ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 165. MEXICO ALLERGY VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 166. MEXICO ALLERGY VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 167. MEXICO ALLERGY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 168. MEXICO ALLERGY VACCINE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 169. MEXICO ALLERGY VACCINE MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 170. MEXICO ALLERGY VACCINE MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 171. MEXICO ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 172. MEXICO ALLERGY VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 173. BRAZIL ALLERGY VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 174. BRAZIL ALLERGY VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 175. BRAZIL ALLERGY VACCINE MARKET SIZE, BY SUBCUTANEOUS IMMUNOTHERAPY, 2018-2024 (USD MILLION)
TABLE 176. BRAZIL ALLERGY VACCINE MARKET SIZE, BY SUBCUTANEOUS IMMUNOTHERAPY, 2025-2030 (USD MILLION)
TABLE 177. BRAZIL ALLERGY VACCINE MARKET SIZE, BY SUBLINGUAL IMMUNOTHERAPY, 2018-2024 (USD MILLION)
TABLE 178. BRAZIL ALLERGY VACCINE MARKET SIZE, BY SUBLINGUAL IMMUNOTHERAPY, 2025-2030 (USD MILLION)
TABLE 179. BRAZIL ALLERGY VACCINE MARKET SIZE, BY ALLERGENS TARGETED, 2018-2024 (USD MILLION)
TABLE 180. BRAZIL ALLERGY VACCINE MARKET SIZE, BY ALLERGENS TARGETED, 2025-2030 (USD MILLION)
TABLE 181. BRAZIL ALLERGY VACCINE MARKET SIZE, BY PERENNIAL ALLERGENS, 2018-2024 (USD MILLION)
TABLE 182. BRAZIL ALLERGY VACCINE MARKET SIZE, BY PERENNIAL ALLERGENS, 2025-2030 (USD MILLION)
TABLE 183. BRAZIL ALLERGY VACCINE MARKET SIZE, BY SEASONAL ALLERGENS, 2018-2024 (USD MILLION)
TABLE 184. BRAZIL ALLERGY VACCINE MARKET SIZE, BY SEASONAL ALLERGENS, 2025-2030 (USD MILLION)
TABLE 185. BRAZIL ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 186. BRAZIL ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 187. BRAZIL ALLERGY VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 188. BRAZIL ALLERGY VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 189. BRAZIL ALLERGY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 190. BRAZIL ALLERGY VACCINE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 191. BRAZIL ALLERGY VACCINE MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 192. BRAZIL ALLERGY VACCINE MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 193. BRAZIL ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 194. BRAZIL ALLERGY VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 195. ARGENTINA ALLERGY VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 196. ARGENTINA ALLERGY VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 197. ARGENTINA ALLERGY VACCINE MARKET SIZE, BY SUBCUTANEOUS IMMUNOTHERAPY, 2018-2024 (USD MILLION)
TABLE 198. ARGENTINA ALLERGY VACCINE MARKET SIZE, BY SUBCUTANEOUS IMMUNOTHERAPY, 2025-2030 (USD MILLION)
TABLE 199. ARGENTINA ALLERGY VACCINE MARKET SIZE, BY SUBLINGUAL IMMUNOTHERAPY, 2018-2024 (USD MILLION)
TABLE 200. ARGENTINA ALLERGY VACCINE MARKET SIZE, BY SUBLINGUAL IMMUNOTHERAPY, 2025-2030 (USD MILLION)
TABLE 201. ARGENTINA ALLERGY VACCINE MARKET SIZE, BY ALLERGENS TARGETED, 2018-2024 (USD MILLION)
TABLE 202. ARGENTINA ALLERGY VACCINE MARKET SIZE, BY ALLERGENS TARGETED, 2025-2030 (USD MILLION)
TABLE 203. ARGENTINA ALLERGY VACCINE MARKET SIZE, BY PERENNIAL ALLERGENS, 2018-2024 (USD MILLION)
TABLE 204. ARGENTINA ALLERGY VACCINE MARKET SIZE, BY PERENNIAL ALLERGENS, 2025-2030 (USD MILLION)
TABLE 205. ARGENTINA ALLERGY VACCINE MARKET SIZE, BY SEASONAL ALLERGENS, 2018-2024 (USD MILLION)
TABLE 206. ARGENTINA ALLERGY VACCINE MARKET SIZE, BY SEASONAL ALLERGENS, 2025-2030 (USD MILLION)
TABLE 207. ARGENTINA ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 208. ARGENTINA ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 209. ARGENTINA ALLERGY VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 210. ARGENTINA ALLERGY VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 211. ARGENTINA ALLERGY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 212. ARGENTINA ALLERGY VACCINE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 213. ARGENTINA ALLERGY VACCINE MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 214. ARGENTINA ALLERGY VACCINE MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 215. ARGENTINA ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 216. ARGENTINA ALLERGY VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 217. EUROPE, MIDDLE EAST & AFRICA ALLERGY VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 218. EUROPE, MIDDLE EAST & AFRICA ALLERGY VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 219. EUROPE, MIDDLE EAST & AFRICA ALLERGY VACCINE MARKET SIZE, BY SUBCUTANEOUS IMMUNOTHERAPY, 2018-2024 (USD MILLION)
TABLE 220. EUROPE, MIDDLE EAST & AFRICA ALLERGY VACCINE MARKET SIZE, BY SUBCUTANEOUS IMMUNOTHERAPY, 2025-2030 (USD MILLION)
TABLE 221. EUROPE, MIDDLE EAST & AFRICA ALLERGY VACCINE MARKET SIZE, BY SUBLINGUAL IMMUNOTHERAPY, 2018-2024 (USD MILLION)
TABLE 222. EUROPE, MIDDLE EAST & AFRICA ALLERGY VACCINE MARKET SIZE, BY SUBLINGUAL IMMUNOTHERAPY, 2025-2030 (USD MILLION)
TABLE 223. EUROPE, MIDDLE EAST & AFRICA ALLERGY VACCINE MARKET SIZE, BY ALLERGENS TARGETED, 2018-2024 (USD MILLION)
TABLE 224. EUROPE, MIDDLE EAST & AFRICA ALLERGY VACCINE MARKET SIZE, BY ALLERGENS TARGETED, 2025-2030 (USD MILLION)
TABLE 225. EUROPE, MIDDLE EAST & AFRICA ALLERGY VACCINE MARKET SIZE, BY PERENNIAL ALLERGENS, 2018-2024 (USD MILLION)
TABLE 226. EUROPE, MIDDLE EAST & AFRICA ALLERGY VACCINE MARKET SIZE, BY PERENNIAL ALLERGENS, 2025-2030 (USD MILLION)
TABLE 227. EUROPE, MIDDLE EAST & AFRICA ALLERGY VACCINE MARKET SIZE, BY SEASONAL ALLERGENS, 2018-2024 (USD MILLION)
TABLE 228. EUROPE, MIDDLE EAST & AFRICA ALLERGY VACCINE MARKET SIZE, BY SEASONAL ALLERGENS, 2025-2030 (USD MILLION)
TABLE 229. EUROPE, MIDDLE EAST & AFRICA ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 230. EUROPE, MIDDLE EAST & AFRICA ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 231. EUROPE, MIDDLE EAST & AFRICA ALLERGY VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 232. EUROPE, MIDDLE EAST & AFRICA ALLERGY VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 233. EUROPE, MIDDLE EAST & AFRICA ALLERGY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 234. EUROPE, MIDDLE EAST & AFRICA ALLERGY VACCINE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 235. EUROPE, MIDDLE EAST & AFRICA ALLERGY VACCINE MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 236. EUROPE, MIDDLE EAST & AFRICA ALLERGY VACCINE MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 237. EUROPE, MIDDLE EAST & AFRICA ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 238. EUROPE, MIDDLE EAST & AFRICA ALLERGY VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 239. EUROPE, MIDDLE EAST & AFRICA ALLERGY VACCINE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 240. EUROPE, MIDDLE EAST & AFRICA ALLERGY VACCINE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 241. UNITED KINGDOM ALLERGY VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 242. UNITED KINGDOM ALLERGY VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 243. UNITED KINGDOM ALLERGY VACCINE MARKET SIZE, BY SUBCUTANEOUS IMMUNOTHERAPY, 2018-2024 (USD MILLION)
TABLE 244. UNITED KINGDOM ALLERGY VACCINE MARKET SIZE, BY SUBCUTANEOUS IMMUNOTHERAPY, 2025-2030 (USD MILLION)
TABLE 245. UNITED KINGDOM ALLERGY VACCINE MARKET SIZE, BY SUBLINGUAL IMMUNOTHERAPY, 2018-2024 (USD MILLION)
TABLE 246. UNITED KINGDOM ALLERGY VACCINE MARKET SIZE, BY SUBLINGUAL IMMUNOTHERAPY, 2025-2030 (USD MILLION)
TABLE 247. UNITED KINGDOM ALLERGY VACCINE MARKET SIZE, BY ALLERGENS TARGETED, 2018-2024 (USD MILLION)
TABLE 248. UNITED KINGDOM ALLERGY VACCINE MARKET SIZE, BY ALLERGENS TARGETED, 2025-2030 (USD MILLION)
TABLE 249. UNITED KINGDOM ALLERGY VACCINE MARKET SIZE, BY PERENNIAL ALLERGENS, 2018-2024 (USD MILLION)
TABLE 250. UNITED KINGDOM ALLERGY VACCINE MARKET SIZE, BY PERENNIAL ALLERGENS, 2025-2030 (USD MILLION)
TABLE 251. UNITED KINGDOM ALLERGY VACCINE MARKET SIZE, BY SEASONAL ALLERGENS, 2018-2024 (USD MILLION)
TABLE 252. UNITED KINGDOM ALLERGY VACCINE MARKET SIZE, BY SEASONAL ALLERGENS, 2025-2030 (USD MILLION)
TABLE 253. UNITED KINGDOM ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 254. UNITED KINGDOM ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 255. UNITED KINGDOM ALLERGY VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 256. UNITED KINGDOM ALLERGY VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 257. UNITED KINGDOM ALLERGY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 258. UNITED KINGDOM ALLERGY VACCINE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 259. UNITED KINGDOM ALLERGY VACCINE MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 260. UNITED KINGDOM ALLERGY VACCINE MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 261. UNITED KINGDOM ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 262. UNITED KINGDOM ALLERGY VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 263. GERMANY ALLERGY VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 264. GERMANY ALLERGY VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 265. GERMANY ALLERGY VACCINE MARKET SIZE, BY SUBCUTANEOUS IMMUNOTHERAPY, 2018-2024 (USD MILLION)
TABLE 266. GERMANY ALLERGY VACCINE MARKET SIZE, BY SUBCUTANEOUS IMMUNOTHERAPY, 2025-2030 (USD MILLION)
TABLE 267. GERMANY ALLERGY VACCINE MARKET SIZE, BY SUBLINGUAL IMMUNOTHERAPY, 2018-2024 (USD MILLION)
TABLE 268. GERMANY ALLERGY VACCINE MARKET SIZE, BY SUBLINGUAL IMMUNOTHERAPY, 2025-2030 (USD MILLION)
TABLE 269. GERMANY ALLERGY VACCINE MARKET SIZE, BY ALLERGENS TARGETED, 2018-2024 (USD MILLION)
TABLE 270. GERMANY ALLERGY VACCINE MARKET SIZE, BY ALLERGENS TARGETED, 2025-2030 (USD MILLION)
TABLE 271. GERMANY ALLERGY VACCINE MARKET SIZE, BY PERENNIAL ALLERGENS, 2018-2024 (USD MILLION)
TABLE 272. GERMANY ALLERGY VACCINE MARKET SIZE, BY PERENNIAL ALLERGENS, 2025-2030 (USD MILLION)
TABLE 273. GERMANY ALLERGY VACCINE MARKET SIZE, BY SEASONAL ALLERGENS, 2018-2024 (USD MILLION)
TABLE 274. GERMANY ALLERGY VACCINE MARKET SIZE, BY SEASONAL ALLERGENS, 2025-2030 (USD MILLION)
TABLE 275. GERMANY ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 276. GERMANY ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 277. GERMANY ALLERGY VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 278. GERMANY ALLERGY VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 279. GERMANY ALLERGY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 280. GERMANY ALLERGY VACCINE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 281. GERMANY ALLERGY VACCINE MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 282. GERMANY ALLERGY VACCINE MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 283. GERMANY ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 284. GERMANY ALLERGY VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 285. FRANCE ALLERGY VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 286. FRANCE ALLERGY VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 287. FRANCE ALLERGY VACCINE MARKET SIZE, BY SUBCUTANEOUS IMMUNOTHERAPY, 2018-2024 (USD MILLION)
TABLE 288. FRANCE ALLERGY VACCINE MARKET SIZE, BY SUBCUTANEOUS IMMUNOTHERAPY, 2025-2030 (USD MILLION)
TABLE 289. FRANCE ALLERGY VACCINE MARKET SIZE, BY SUBLINGUAL IMMUNOTHERAPY, 2018-2024 (USD MILLION)
TABLE 290. FRANCE ALLERGY VACCINE MARKET SIZE, BY SUBLINGUAL IMMUNOTHERAPY, 2025-2030 (USD MILLION)
TABLE 291. FRANCE ALLERGY VACCINE MARKET SIZE, BY ALLERGENS TARGETED, 2018-2024 (USD MILLION)
TABLE 292. FRANCE ALLERGY VACCINE MARKET SIZE, BY ALLERGENS TARGETED, 2025-2030 (USD MILLION)
TABLE 293. FRANCE ALLERGY VACCINE MARKET SIZE, BY PERENNIAL ALLERGENS, 2018-2024 (USD MILLION)
TABLE 294. FRANCE ALLERGY VACCINE MARKET SIZE, BY PERENNIAL ALLERGENS, 2025-2030 (USD MILLION)
TABLE 295. FRANCE ALLERGY VACCINE MARKET SIZE, BY SEASONAL ALLERGENS, 2018-2024 (USD MILLION)
TABLE 296. FRANCE ALLERGY VACCINE MARKET SIZE, BY SEASONAL ALLERGENS, 2025-2030 (USD MILLION)
TABLE 297. FRANCE ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 298. FRANCE ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 299. FRANCE ALLERGY VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 300. FRANCE ALLERGY VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 301. FRANCE ALLERGY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 302. FRANCE ALLERGY VACCINE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 303. FRANCE ALLERGY VACCINE MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 304. FRANCE ALLERGY VACCINE MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 305. FRANCE ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 306. FRANCE ALLERGY VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 307. RUSSIA ALLERGY VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 308. RUSSIA ALLERGY VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 309. RUSSIA ALLERGY VACCINE MARKET SIZE, BY SUBCUTANEOUS IMMUNOTHERAPY, 2018-2024 (USD MILLION)
TABLE 310. RUSSIA ALLERGY VACCINE MARKET SIZE, BY SUBCUTANEOUS IMMUNOTHERAPY, 2025-2030 (USD MILLION)
TABLE 311. RUSSIA ALLERGY VACCINE MARKET SIZE, BY SUBLINGUAL IMMUNOTHERAPY, 2018-2024 (USD MILLION)
TABLE 312. RUSSIA ALLERGY VACCINE MARKET SIZE, BY SUBLINGUAL IMMUNOTHERAPY, 2025-2030 (USD MILLION)
TABLE 313. RUSSIA ALLERGY VACCINE MARKET SIZE, BY ALLERGENS TARGETED, 2018-2024 (USD MILLION)
TABLE 314. RUSSIA ALLERGY VACCINE MARKET SIZE, BY ALLERGENS TARGETED, 2025-2030 (USD MILLION)
TABLE 315. RUSSIA ALLERGY VACCINE MARKET SIZE, BY PERENNIAL ALLERGENS, 2018-2024 (USD MILLION)
TABLE 316. RUSSIA ALLERGY VACCINE MARKET SIZE, BY PERENNIAL ALLERGENS, 2025-2030 (USD MILLION)
TABLE 317. RUSSIA ALLERGY VACCINE MARKET SIZE, BY SEASONAL ALLERGENS, 2018-2024 (USD MILLION)
TABLE 318. RUSSIA ALLERGY VACCINE MARKET SIZE, BY SEASONAL ALLERGENS, 2025-2030 (USD MILLION)
TABLE 319. RUSSIA ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 320. RUSSIA ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 321. RUSSIA ALLERGY VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 322. RUSSIA ALLERGY VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 323. RUSSIA ALLERGY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 324. RUSSIA ALLERGY VACCINE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 325. RUSSIA ALLERGY VACCINE MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 326. RUSSIA ALLERGY VACCINE MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 327. RUSSIA ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 328. RUSSIA ALLERGY VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 329. ITALY ALLERGY VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 330. ITALY ALLERGY VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 331. ITALY ALLERGY VACCINE MARKET SIZE, BY SUBCUTANEOUS IMMUNOTHERAPY, 2018-2024 (USD MILLION)
TABLE 332. ITALY ALLERGY VACCINE MARKET SIZE, BY SUBCUTANEOUS IMMUNOTHERAPY, 2025-2030 (USD MILLION)
TABLE 333. ITALY ALLERGY VACCINE MARKET SIZE, BY SUBLINGUAL IMMUNOTHERAPY, 2018-2024 (USD MILLION)
TABLE 334. ITALY ALLERGY VACCINE MARKET SIZE, BY SUBLINGUAL IMMUNOTHERAPY, 2025-2030 (USD MILLION)
TABLE 335. ITALY ALLERGY VACCINE MARKET SIZE, BY ALLERGENS TARGETED, 2018-2024 (USD MILLION)
TABLE 336. ITALY ALLERGY VACCINE MARKET SIZE, BY ALLERGENS TARGETED, 2025-2030 (USD MILLION)
TABLE 337. ITALY ALLERGY VACCINE MARKET SIZE, BY PERENNIAL ALLERGENS, 2018-2024 (USD MILLION)
TABLE 338. ITALY ALLERGY VACCINE MARKET SIZE, BY PERENNIAL ALLERGENS, 2025-2030 (USD MILLION)
TABLE 339. ITALY ALLERGY VACCINE MARKET SIZE, BY SEASONAL ALLERGENS, 2018-2024 (

Samples

Loading
LOADING...

Companies Mentioned

  • ALK-Abelló A/S
  • Stallergenes Greer LLC
  • Allergopharma GmbH & Co. KG
  • Merck & Co., Inc.
  • DBV Technologies S.A.
  • Allergy Therapeutics plc
  • Laboratorios LETI, S.L.
  • HAL Allergy B.V.
  • Bencard Allergie GmbH
  • Torii Pharmaceutical Co., Ltd.

Table Information

Report AttributeDetails
No. of Pages195
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 1.6 Billion
Forecasted Market Value ( USD ) by 2030 $ 2.75 Billion
Compound Annual Growth Rate11.5%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Allergy Vaccine Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Allergy Vaccine Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 180 Pages
  • Global
From
Allergy Vaccines - Global Strategic Business Report - Product Image

Allergy Vaccines - Global Strategic Business Report

  • Report
  • 481 Pages
  • Global
From
Peanut Allergy Vaccine Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Image

Peanut Allergy Vaccine Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • 150 Pages
  • Global
From
Allergy Immunotherapy Market - Global Forecast 2025-2030 - Product Image

Allergy Immunotherapy Market - Global Forecast 2025-2030

  • Report
  • 182 Pages
  • Global
From
Allergy Immunotherapy Market Report 2025 - Product Image

Allergy Immunotherapy Market Report 2025

  • Report
  • 200 Pages
  • Global
From

About the Market

The Allergy Vaccine market is a subset of the Vaccines market, which is composed of products designed to prevent or reduce the severity of infectious diseases. Allergy Vaccines are specifically designed to reduce the severity of allergic reactions, such as hay fever, asthma, and food allergies. These vaccines are typically administered through a series of injections, which can be tailored to the individual patient's needs. Allergy Vaccines are becoming increasingly popular as a way to reduce the burden of allergic reactions, and are being used in both adults and children. They are also being used in combination with other treatments, such as antihistamines and immunotherapy, to provide a more comprehensive approach to managing allergies. Some companies in the Allergy Vaccine market include ALK-Abello, Stallergenes Greer, Allergy Therapeutics, and DBV Technologies. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.